Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis

Annals of Hematology

Volumn 72, Issue 4, 1996, Pages 208-215

  Amadori, S ^a   Venditti, A ^a   Del Poeta, G ^a   Stasi, R ^a   Buccisano, F ^a   Bruno, A ^a   Tamburini, A ^a   Cox, M C ^a   Maffei, L ^a   Aronica, G ^a   Simone, M D ^a   Adorno, G ^a   Masi, M ^a   Tribalto, M ^a   Papa, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

AML M0; Anti MPO; Complex karyotypes; MDR phenotype

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CD7 ANTIGEN; CELL MARKER; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER SURVIVAL; CLINICAL FEATURE; CYTOGENETICS; DISEASE CLASSIFICATION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPHENOTYPING; MULTIDRUG RESISTANCE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; PROGNOSIS;

EID: 15844385781     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050162     Document Type: Article

References (65)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukemias (FAB Cooperative Group). Br J Haematol 33:451-458
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:620-629
3. Lee EJ, Pollak A, Leavitt RD, Testa JR, Schiffer CA (1987) Minimally differentiated acute nontymphocytic leukemia: a distinct entity. Blood 70:1400-1406
4. Matutes E, Pombo de Oliveira, Foroni L, Morilla R, Catovsky D (1988) The role of ultrastructural cytochemistry in clarifying the nature of undifferentiated cells in acute leukemia. Br J Haematol 69:205-211
5. Campos L, Guyotat D, Archimbaud E, Devaux Y, Treille D, Larese A, Maupas J, Gentilhomme O, Ehrsam A, Fiere D (1989) Surface marker expression in adult acute myeloid leukemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol 72:161-166
6. Venditti A, Del Poeta G, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone MD, Tribalto M, Amadori S, Papa G (1994) Minimally differentiated acute myeloid leukemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br J Haematol 88:784-793
7. Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G (1994) Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood 6:1619-1625
8. Catovsky D, Matutes E, Buccheri V, Shetry V, Manslip J, Yoshida N, Morilla R (1991) A classification of acute leukemia for 1990s. Ann Hematol 62:16-21
9. Segeren CM, de Jong-Gerritis GCMM, van't Veer MB (Dutch Slide Review Committee of Leukemia in Adults) (1995) AML-M0: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Ann Hematol 70:297-300
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (FAB Cooperative Group) (1991) Proposals for the recognition of minimally differentiated acute myeloid leukemia (AML-M0) Br J Haematol 78:325-329
11. Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, Van Orshoven A, Criel A, Stul M, Dal Cin P, Hemandez J. Chatelain B, Doyen C, Louwagie A, Castoldi G, Cassiman JJ, Van Den Berghe H (1995) Cytogenetic profile of minimally differentiated (FAB MO) acute myeloid leukemia: correlation with clinicobiologic findings. Blood 12:3688-3694
12. Venditti A, Del Poeta G, Stasi R, Buccisano F, Aronica G, Bruno A, Cox C, Maffei L, Papa G, Amadori S (1995) Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implications (letter). Blood (in press)]
13. Shetty V, Chitale A, Matutes E, Buccheri V, Morilla R, Catovsky D (1993) Immunological and ultrastructural studies in acute biphenotypic leukemia. J Clin Pathol 46:903-907
14. van der Schoot CE, Daams GM, Pinkster J, Vet R, von dem Borne AEGK (1990) Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukemia. Br J Haematol 74:173-178
15. Koeffler HP, Ranyard J, Pertcheck M (1985) Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 65:484-491
16. Praxedes MK, De Oliveira LZ, Pereira WV, Quintana IZ, Tabak DG, De Oliveira MS (1994) Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukemia. Leuk Lymphoma 12:233-239
17. Campana D, Hanse-Hagge E, Matutes E, Coustan-Srnith E, Yokota S, Shetty V, Bartram CR, Janossy G (1990) Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia. Leukemia 4:620-624
18. Pombo de Oliveira, Matutes E, Rani S, Morilla R, Catovsky D (1988) Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukemia. Acta Haematol 8:61-64
19. Parreira A, Pombo de Oliveira MS, Matutes E, Foroni L, Morilla R, Catovsky D (1988) Terminal deoxynucleotidyl transferase positive acute myeloid leukemia: an association with immature myeloblastic leukemia. Br J Haematol 69:219-224
20. Lo Coco F, De Rossi G, Pasqualetti D, Lopez M, Diverio D, Latagliata R, Fenu S, Mandelli F (1989) CD7 positive acute myeloid leukemia: a subtype associated with cell immaturity. Br J Haematol 73:480-485
21. Kurtzberg J, Waldmann TA, Davcy MP, Bigner SH, Moore JO, Hersfield MS, Haynes BF (1989) CD7+, CD4-. CD8-acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 73:381-390
22. Zutter MM, Martin PJ, Deene Hanke, Kidd PG (1990) CD7+ acute nonlymphocytic leukemia: evidence for an early multipotential progenitor. Leuk Res 14:23-26
23. Bollum FJ. (1979) Terminal deoxynucleotidyl transferase as a hemopoietic cell marker. Blood 54:1203-1215
24. Desiderio SV, Yancopoulus GD, Paskind M, Thomas E, Boss MA, Landau N, Alt FW, Baltimore D (1984) Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxynucleotidyl transferase in B cells. Nature 311:752-755
25. Foa R, Casorati G, Giubellino MC, Basso G, Schiro R, Pizzolo G, Lauria F, Lefranc MP, Rabbitts TH, Mingone N (1987) Rearrangements of immunoglobulin and T cell receptor b and g genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia. J Exp Med 165:879-890
26. Bradstock KF, Hewson J, Kerr A, Kabral A, Lee CH, Hughes WG (1983) Expression of terminal deoxynucleotidyl transferase in malignant myeloblasts. Am J Clin Pathol 80:800-805
27. Bradstock KF, Hoffbrand AV, Ganeshaguru K, Liewellin P, Patterson K, Wonke B, Prentice AG, Bennett M, Pizzolo G, Bollum FJ, Janossy G (1981) Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukemia: an analysis by immunofluorescence. Br J Haematol 47:133-143
28. Catovsky D, Cardullo L, O'Brien M, Morilla R, Costello C, Galton DAG, Ganeshaguru D, Hoffbrand K (1981) Cytochemical markers of differentiation in acute leukemia. Cancer Res 41:4824-4832
29. Mc Graw TP, Folds JD, Bollum FJ, Stass SA (1981) Terminal deoxynucleotidyltransferase-positive acute myeloblastic leukemia. Am J Hematol 10:251-258
30. Pui CH, Dahl GV, Melvin S, Williams DL, Peiper S, Mirro J, Murphy SB, Stass S (1984) Acute leukemia with mixed lymphoid and myeloid phenotype 56:121-130
31. San Miguel JF, Gonzales M, Canizo MC, Anta JP, Portero JA, Lopez-Borrasca A (1986) Tdt activity in acute myeloid leukemias defined by monoclonal antibodies. Am J Hematol 23:9-17
32. Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A, Schiffer CA (1992) The significance of CD34 and Tdt determination in patients with untreated de novo acute myeloid leukemia. Leukemia 6:1203-1209
33. Haynes BF, Mann DL, Shroer ME, Shelhamer JA, Eisenbarth JH, Strominger JE, Thomas CA, Mostowki HS. Fauci AS (1980) Characterization of a monoclonal antibody that defines an immunoregulatory T-cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci USA 77:2914-2918
34. Pittaluga S, Raffeld M, Lipford EH, Cossman J (1986) 3A1 (CD7) expression preceds T B gene rearrangements in precursor T (lymphoblastic) neoplasms. Blood 68:134-137
35. Vodinelich L, Tax W, Bai Y, Pegram S, Capel P, Greaves MF (1983) A monoclonal antibody (WT1) for detecting leukemias of T-cell precursors (T-ALL). Blood 62:1108-1113
36. Lopez M, De Rossi G, Bonomo G, Ranucci A, Guglielmi C, Pasqualetti D, Vitale A, Mandelli F (1985) Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia. Diagn Immunol 3:11-14
37. Harden EA, Haynes BF (1985) Phenotypic and functional characterization of human malianant T cells. Semin Hematol 22:13-18
38. Foon Ka, Todd RA (1986) Immunologic classification of leukemia and lymphoma. Blood 68:1-8
39. Reading CL, Estey EH, Huh YO, Claxton DF, Sanchez G, Terstappen LWMM, O'Brien MC, Baron S. Deisseroth A (1993) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 81:3083-3090
40. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetamy T, Allen SL, Rai K, Lee EJ, Schiffer CA, Bloomfield CD (1991) 10:2242-2250
41. Bradstock K, Matthews J, Benson E, Page F, Bishop J (Australian Leukemia Study Group) (1994) Prognostic value of immunophenotyping in acute myeloid leukemia. Blood 84:1220-1225
42. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Karaada N, Nasu K, Uchino H (The Japan Cooperative Group of Leukemia/Lymphoma) (1993) Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 81:2399-2405
43. Cross AH, Goorha RM, Nuss R, Behm FG, Murphy SB, Kalwinsky DK, Raimondi S, Kitchingman GR. Mirro J (1988) Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood 72:579-587
44. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G. Bruno A, Masi M, Tabilio A, Papa G (1994) Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 8:388:394
45. Del Poeta G, Stasi R, Venditti A, Masi M, Papa G (1993) CD7 expression in acute myeloid leukemia (letter). Blood 82:2929-2930
46. Chabannon C, Wood P, Torok-Storb B (1992) Expression of CD7 on normal human myeloid progenitors. J Immunol 149:2110-2113
47. Buccheri V, Matutes E, Dyer MJ, Catovsky D (1993) Lineage commitment in biphenotypic acute leukemia. Leukemia 7:919-924
48. List AF, Spier CM, Cline A, Doll DC, Garewl H, Morgan R, Sandberg AA (1991) Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br J Haematol 78:28-34
49. Del Poeta G, Stasi R, Aronica G, Venditti A, Cox MC, Bruno A, Buccisano F, Masi M, Tribalto M, Amadori S, Papa G (1995) Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood (in press)
50. Cox-Froncillo MC, Zollino M, Del Poeta G, Bajer J, Stasi R, Venditti A, Tribalto M, Neri G, Papa G (1995) Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (AML-M0). Cancer Genet Cytogenet 80:66-67
51. Keung YK, Kaplan B, Douer D (1994) Biphenotypic MO acute myeloid leukemia with trisomy 4. Leuk Lymphoma 14:181-184
52. Yamagami T, Sugiyama H, Ogawa H, Matsunashi T, Sasaki K. Kishimoto T, Taniwaki M, Abe T (1994) A novel case of acute myeloid leukemia of MO form with t(10;11)(p13;q21) (letter). Am J Hematol 47:64-65
53. Kao YS, McCormick C, Vial R (1990) Trisomy 4 in a case of acute undifferentiated myeloblastic leukemia with hand-mirror cells. Cancer Genet Cytogenet 45:265-268
54. Yokose N, Ogata K, Ito T, Miyake K, An E, Inokuchi K, Yamada T, Gomi S, Tanabe Y, Ohki I, Kuwaba T, Hasegawa S, Shinohara T, Dan K, Nomura T (1993) Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). Ann Hematol 66:67-70
55. Sreekantaih C, Baer MR, Morgan S, Isaacs JD, Miller KB, Sandeberg AA (1990) Trisomy/tetrasomy in seven cases of acute leukemia. Leukemia 4:781-785
56. Baer MR. Bloomfield (1992) Trisomy 13 in acute leukemia. Leuk Lymphoma 7:1-5
57. Oster W, Konig K, Ludwig WD, Ganser A, Lindemann A, Mertelsmann R, Herrmann F (1988) Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping. Leuk Res 12:887-892
58. Knowles DM, Della Favera R, Pelicci PG (1985) T-cell receptor beta chain rearrangements. Lancet 2:159-163
59. McCulloch EA. (1983) Stem cells in normal and leukemic hemopoiesis. Blood 62:1-10
60. Chen GY, Minden MD, Toyonaga B, Mak TW, McCulloch EA (1986) T-cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia. J Exp Med 163:414-424
61. Greaves MF, Chan LC, Furley AJW, Watt JM, Molgaard HV (1986) Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67:1-11
62. Norton JD, Campana D, Hoffbrand AV, Janossy G, Counstain-Smith E, Jani H, Yaxley JC, Prentice HG (1987) Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. Leukemia 1:757-761
63. Foon KA, Naiem F, Yale C, Gale RP (1979) Acute myelogenous leukemia: morphologic classification and response to therapy , Leuk. Res 2:171-176
64. Mertelsmann R, Thaler HT, To L, Gee TS, McKenzie S, Schauer P, Friedman A, Arlin Z, Cirrinicione C, Clarkson B (1980) Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood 56:773-778
65. Reiffers J, Broustet A (1981) Acute myeloblastic leukemia masquerading as null-cell Iymphoblastic leukemia. N Engl J Med 304:1238-1243